Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids

Ulipristal acetate (UPA) is a medical treatment for uterine fibroids and was authorized for surgical pre-treatment in 2012 after the conduct of the PEARL I and II randomized controlled trials and for intermittent treatment after the observational PEARL III and IV trials. However, UPA came into disre...

Descripción completa

Detalles Bibliográficos
Autores principales: Middelkoop, Mei-An, de Lange, Maria E, Clark, T Justin, Mol, Ben Willem J, Bet, Pierre M, Huirne, Judith A F, Hehenkamp, Wouter J K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071218/
https://www.ncbi.nlm.nih.gov/pubmed/35143669
http://dx.doi.org/10.1093/humrep/deac009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071218/
https://www.ncbi.nlm.nih.gov/pubmed/35143669
http://dx.doi.org/10.1093/humrep/deac009

Ejemplares similares